TCT-576 Primary Endpoint Results from the PROMUS Element Plus US Post-Approval Study (PE-Plus PAS): 1-Year Outcomes in Real-World Patients Treated With a Thin-Strut, Platinum-Chromium, Everolimus-Eluting Stent

Background The PE Plus Post-Approval Study (PE Plus PAS) was designed to examine outcomes among patients treated with advanced generation, everolimus-eluting, platinum chromium PROMUS Element stents (Boston Scientific, Natick, MA) over 5 years in a 'real-world setting'.

Saved in:
Bibliographic Details
Published inJournal of the American College of Cardiology Vol. 64; no. 11; p. B167
Main Authors Kandzari, David, Amjadi, Nima, Caputo, Christopher, Rowe, Steven K, Williams, Jerome, Tamboli, Hoshedar P
Format Journal Article
LanguageEnglish
Published New York Elsevier Inc 16.09.2014
Elsevier Limited
Subjects
Cardiology
Cardiovascular
Heart attacks
Internal Medicine
Medical research
Patients
Platinum
Stents
Online AccessGet full text

Cover

More Information
Summary:Background The PE Plus Post-Approval Study (PE Plus PAS) was designed to examine outcomes among patients treated with advanced generation, everolimus-eluting, platinum chromium PROMUS Element stents (Boston Scientific, Natick, MA) over 5 years in a 'real-world setting'.
ISSN:0735-1097
1558-3597
DOI:10.1016/j.jacc.2014.07.639